ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
05 Jul 2017

Acarix Receives First German Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin

Malmö, July 5, 2017 Acarix Receives First German Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease Fr...
Continue reading
author-avatar acarix
Press
August 6, 2024
13 Jun 2017

Acarix får sin första kommersiella order för CADScor®System för tidig upptäckt av kranskärlssjukdom från danskt sjukhus

Pressmeddelande Malmö, 13 juni, 2017 Acarix får sin första kommersiella order för CADScor®System för tidig upptäckt av kranskärlssjukd...
Continue reading
author-avatar acarix
Press
August 6, 2024
13 Jun 2017

Acarix Receives First Commercial Order For CADScor®System For Early Detection Of Coronary Artery Disease From Danish Hospital

Press release Malmö, June 13, 2017 Acarix Receives First Commercial Order For CADScor®System For Early Detection Of Coronary Artery D...
Continue reading
author-avatar acarix
Press
August 6, 2024
24 May 2017

Acarix publicerar delårsrapport för januari – mars 2017

Pressmeddelande från Acarix AB (publ) 2017-05-24 Acarix publicerar delårsrapport för januari - mars 2017 Idag, onsdagen den 24 majl, pu...
Continue reading
author-avatar acarix
Press
August 6, 2024
24 May 2017

Acarix publishes the Interim Report for the period January – March 2017

Press release from Acarix AB (publ) 2017-05-24 Acarix publishes the Interim Report for the period January - March 2017 Today, Wednesday...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Apr 2017

Acarix publishes the 2016 Annual Report

Press release from Acarix AB (publ) 2017-04-18 Acarix publishes the 2016 Annual Report Today, Tuesday April 18, Acarix is publishing it...
Continue reading
author-avatar acarix
Press
August 6, 2024
18 Apr 2017

Acarix publicerar årsredovisningen för 2016

Pressmeddelande från Acarix AB (publ) 2017-04-18 Acarix publicerar årsredovisningen för 2016 Idag, tisdagen den 18 april, publicerar Ac...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Mar 2017

Multicenterstudie med Acarix CADScor®System bekräftar tidigare preliminära resultat att CADScor®System kan utesluta CAD med 97% negativt prediktivt värde.

Press release Malmö 17 mars 2017 Multicenterstudie med Acarix CADScor®System bekräftar tidigare preliminära resultat att CADScor®System...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Mar 2017

Acarix CADScor®System multi-center trial results confirms previous preliminary results of CADScor®System ruling out CAD with 97% negative predictive value

Press release Malmö March 17, 2017 Acarix CADScor®System multi-center trial results confirms previous preliminary results of CADScor®Sy...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Feb 2017

Acarix presents Year-end Report, January – December 2016

Year-end Report, January - December 2016 Completed listing prepares Acarix for commercialization of CADScor®System "Heart disease ...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Feb 2017

Acarix presenterar bokslutskommuniké, januari – december 2016

Bokslutskommuniké, januari - december 2016 Acarix inleder kommersialisering av CADScor®System efter notering "Hjärtsjukdomar är de...
Continue reading
  • «
  • ‹
  • 7
  • 8
  • 9
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.